The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of a phase 1, first-in-human study of talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D) × CD3 bispecific antibody, in relapsed/refractory multiple myeloma (MM).
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Secura Bio (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); Constellation Pharmaceuticals (Inst); crispr therapeutics (Inst); CURIS (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Glenmark (Inst); Ichnos Sciences (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - BMS
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Pfizer; Regeneron
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Celgene
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Cellectis; Janssen; Novartis
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Sanofi; Takeda
 
Elham Askari
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Celgene; Janssen
Speakers' Bureau - Celgene; Janssen
Travel, Accommodations, Expenses - Janssen
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Monique C. Minnema
Consulting or Advisory Role - Alnylam; Bristol-Myers Squibb; Gilead Sciences; Janssen-Cilag
Travel, Accommodations, Expenses - Celgene
 
Luciano J. Costa
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Karyopharm Therapeutics
Speakers' Bureau - Amgen; Sanofi
Research Funding - Amgen; Janssen
 
Raluca Verona
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Suzette Girgis
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Thomas Prior
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Brandi Hilder
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen
 
Jeffery Scott Russell
Employment - Janssen
Stock and Other Ownership Interests - Janssen Research & Development
 
Jenna D. Goldberg
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda